Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 8, Pages 910
Publisher
MDPI AG
Online
2021-08-17
DOI
10.3390/vaccines9080910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection
- (2021) Pauline Vetter et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- The coronavirus is here to stay — here’s what that means
- (2021) Nicky Phillips NATURE
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India
- (2021) Jayanthi Shastri et al. Frontiers in Medicine
- Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
- (2021) Ayelet Grupper et al. Clinical Journal of the American Society of Nephrology
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistence of Antibody and Cellular Immune Responses in COVID-19 patients over Nine Months after Infection
- (2021) Lin Yao et al. JOURNAL OF INFECTIOUS DISEASES
- COVID-19 reinfection: a rapid systematic review of case reports and case series
- (2021) Jingzhou Wang et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
- (2021) Cielo García-Montero et al. Vaccines
- Cellular and humoral response after MRNA‐1273 SARS‐CoV‐2 vaccine in kidney transplant recipients
- (2021) David Cucchiari et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
- (2021) Diana Rodríguez-Espinosa et al. KIDNEY INTERNATIONAL
- AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
- (2021) Emma C Wall et al. LANCET
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- A ‘mix and match’ approach to SARS-CoV-2 vaccination
- (2021) Meagan E. Deming et al. NATURE MEDICINE
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
- (2021) Tina Schmidt et al. NATURE MEDICINE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 vaccination and dialysis patients: why the variable response
- (2021) J -S Yen et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
- (2021) Allison J. Greaney et al. Science Translational Medicine
- Early experience with SARs‐CoV‐2 mRNA vaccine breakthrough among kidney transplant recipients
- (2021) Chelsey Chenxi Song et al. Transplant Infectious Disease
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Interpreting Diagnostic Tests for SARS-CoV-2
- (2020) Nandini Sethuraman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recurrence of positive SARS‐CoV‐2 in patients recovered from COVID‐19
- (2020) Van Thuan Hoang et al. JOURNAL OF MEDICAL VIROLOGY
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- (2020) Kelvin Kai-Wang To et al. LANCET INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- The COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
- (2020) Katharine H. D. Crawford et al. Viruses-Basel
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study
- (2020) Andrea Padoan et al. CLINICA CHIMICA ACTA
- Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
- (2020) Caroline Atyeo et al. IMMUNITY
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
- (2020) Zhe Lv et al. SCIENCE
- COVID-19 diagnostics in context
- (2020) Ralph Weissleder et al. Science Translational Medicine
- SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
- (2020) He-wei Jiang et al. Nature Communications
- A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
- (2020) Antonio E. Muruato et al. Nature Communications
- Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development
- (2020) Sayeh Ezzikouri et al. Human Vaccines & Immunotherapeutics
- The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
- (2020) Lakshmanane Premkumar et al. Science Immunology
- Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
- (2020) Ferdinand Zettl et al. Vaccines
- A history of herd immunity
- (2020) David Jones et al. LANCET
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
- (2020) Denis Y Logunov et al. LANCET
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Understanding protection from SARS-CoV-2 by studying reinfection
- (2020) Julie Overbaugh NATURE MEDICINE
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
- (2020) Jianhui Nie et al. Nature Protocols
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding COVID-19 vaccine efficacy
- (2020) Marc Lipsitch et al. SCIENCE
- Vaccines based on replication incompetent Ad26 viral vectors: standardized template with key considerations for a risk/benefit assessment
- (2020) Jerome Custers et al. VACCINE
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
- (2020) Anita S. Iyer et al. Science Immunology
- A simple protein-based surrogate neutralization assay for SARS-CoV-2
- (2020) Kento T. Abe et al. JCI Insight
- Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
- (2020) Lauren B. Rodda et al. CELL
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- A case of COVID-19 reinfection in the UK
- (2020) Jack West et al. CLINICAL MEDICINE
- The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
- (2020) Jung-Hyun Won et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
- (2020) Takehiro Ura et al. VACCINE
- Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
- (2020) Anwar M. Hashem et al. Viruses-Basel
- The development of neutralizing antibodies against SARS-CoV-2 and their common features
- (2020) Liu Daisy Liu et al. Journal of Molecular Cell Biology
- Humoral Responses and Serological Assays in SARS-CoV-2 Infections
- (2020) Yannick Galipeau et al. Frontiers in Immunology
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
- (2020) Susanne H Hodgson et al. LANCET INFECTIOUS DISEASES
- Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2015) Victor M. Corman et al. CLINICAL INFECTIOUS DISEASES
- Serological assays for emerging coronaviruses: Challenges and pitfalls
- (2014) Benjamin Meyer et al. VIRUS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now